Study of the Safety and Immunogenicity of NasoVAX Extension
Clinical trial NCT03760549 · COMPLETED
Trial details
- NCT number
- NCT03760549
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-21
- Primary completion
- 2019-02-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.